维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="Foster GR"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA显示文摘	Foster GR Ackrill AM Goldin DR	1995	Proc Natl Acad Sci USA1995，92，8：	1
2	Effect of narrow grassstrips on conservation reserve land converted to cropland 显示文摘	Raffaelle Jr JB McGregor KC Foster GR	1997	Transactions of the ASAE1997，40，6：	1
3	Pegylated interferons for the treatment of chronic hepatitis C:pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b显示文摘	Foster GR	2010	Drugs2010，70，2：	1
4	Are all type I human interferons equivalent显示文摘	Foster GR Finter NB	1998	J Viral Hepat1998，5，3：	1
5	Increase in primary liver cancer in the UK, 1979-94显示文摘	Taylor-Robinson SD Foster GR Arora S	1997	Lancet1997，350，：	1
6	Mulch cover and canopy effect on soil loss显示文摘	Khan M J Monke EJ Foster GR	1988	Transactions of the ASAE1988，31，3：	1
7	The way forward in HCV treatment--finding the right path显示文摘	Manns MP Foster GR Rockstroh JK	2007	Nat Rev Drug Diseov2007，6，12：	1
8	Estimation of erosion in- dex from daily rainfall amount 显示文摘	Richardson CW Foster GR Wright DA	1983	Transactions of the ASAE1983，26，：	1
9	Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection 显示文摘	Foster GR Afdhal N Roberts SK	2015	N Engl J Med2015，373，：	1
10	Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin显示文摘	Foster GR Fried MW Hadziyannis S J	2007	Scand J Gastroentero2007，42，2：	1
11	IFN-α subtypes differentially affect human T cell motility显示文摘	Foster GR Masri SH David R	2004	J Immunol2004，173，3：	1
12	Influencing factors on the outcome and prognosis of patients with HBV infc- tion: seven years follow-up显示文摘	Sali S Alavian SM Foster GR	2013	Hepat Mon2013，13，7：	1
13	A ctivity of telaprevir alone or in combination with peginterferon alfa-2a and ribavirin in treatment-naive genotype 2 and 3 hepatitis-c patients:interim results of study c209显示文摘	Foster GR Hezode C Bronowicki JP		Journal of Hepatology0，，：	1
14	Telaprevir for retreatment of HCV infection 显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team	2011	N Engl J Med2011，364，25：	1
15	Comparative characterization of gingival and periodontal ligament cells,in vito显示文摘	Hokama MM Foster RA Archer SY Imm GR	1987	J Dent Res1987，66，：	1
16	Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis显示文摘	Foster GR Goldin RD Thomas HC	1998	Hepatology1998，27，1：	1
17	Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferon alpha and gamma and double-stranded RNA显示文摘	Foster GR Ackrill AM Goldin RD	1991	Proc Natl Acad Sci USA1991，88，7：	1
18	Increase in primary liver cancer in the UK, 1979 - 94 显示文摘	Taylor - Robinson SD Foster GR Arora S	1997	Lancet1997，350，9085：	1
19	Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy显示文摘	Foster GR Golden RD Hay A	1993	Hepatology1993，17，75：	1
20	The way forward in HCV treatment finding the right path显示文摘	MANNS MP FOSTER GR ROCKSTROH JK	2007	Nat Rev Drug Discov2007，6，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示